Advances in Coronary Heart Disease

Coronary heart disease (CHD), also known as coronary artery disease, is a group of diseases that includes: stable angina, unstable angina, myocardial infarction, and sudden cardiac death. In 2013, CHD was the most common cause of death globally, resulting in 8.14 million deaths (16.8%) up from 5.74 million deaths (12%) in 1990. The risk of death from CHD for a given age has decreased between 1980 and 2010 especially in developed countries. The number of cases of CHD for a given age has also decreased between 1990 and 2010. Since the 1990s the search for new treatment options for coronary artery disease patients, particularly for so called "no-option" coronary patients, focused on usage of angiogenesis and stem cell therapies. Numerous clinical trials were performed, either applying protein (angiogenic growth factor) therapies, such as FGF-1 or VEGF, or cell therapies using different kinds of adult stem cell populations. Research is still going on with first promising results particularly for FGF-1 and utilization of endothelial progenitor cells.

 

In the present book, fifteen typical literatures about coronary heart disease published on international authoritative journals were selected to introduce the worldwide newest progress, which contains reviews or original researches on medical science, aging-associated disease, heart diseases, ischemic heart disease, ect. We hope this book can demonstrate advances in coronary heart disease as well as give references to the researchers, students and other related people.

Components of the Book:
  • Chapter 1
    Analysing Horizontal Equity in Enrolment in Disease Management Programmes for Coronary Heart Disease in Germany 2008–2010
  • Chapter 2
    Patients’ Perceptions of Depression and Coronary Heart Disease: A Qualitative UPBEAT-UK Study
  • Chapter 3
    Cost-Effectiveness of a Coronary Heart Disease Secondary Prevention Program in Patients with Myocardial Infarction: Results from a Randomised Controlled Trial (ProActive Heart)
  • Chapter 4
    A Case-Control Validation of Type D Personality in Greek Patients with Stable Coronary Heart Disease
  • Chapter 5
    Evaluation of the Prevalence of Coronary Artery Disease in Patients with Valvular Heart Disease
  • Chapter 6
    Clinical Assessment of Shenfu Injection Loading in the Treatment of Patients with Exacerbation of Chronic Heart Failure Due to Coronary Heart Disease: Study Protocol for a Randomized Controlled Trial
  • Chapter 7
    Cytochrome P450 2C19*2 Polymorphism in Patients with Stable Coronary Heart Disease and Risk for Secondary Cardiovascular Disease Events: Results of a Long-Term Follow-Up Study in Routine Clinical Care
  • Chapter 8
    Effect of Ivabradine-Induced Heart Rate Reduction on Flow-Mediated Dilation Measured with High-Sensitivity Ultrasound in Patients with Stable Coronary Heart Disease
  • Chapter 9
    Effect of SORT1, APOB and APOE Polymorphisms on LDL-C and Coronary Heart Disease in Pakistani Subjects and Their Comparison with Northwick Park Heart Study II
  • Chapter 10
    Is Inflammatory Chronic Obstructive Pulmonary Disease a Coronary Heart Disease Risk Equivalent? A Longitudinal Analysis of the Third National Health and Nutrition Examination Survey (NHANES III), 1988–1994
  • Chapter 11
    The ApoB100/ApoAI Ratio Is Independently Associated with the Severity of Coronary Heart Disease: A Cross Sectional Study in Patients Undergoing Coronary Angiography
  • Chapter 12
    The Effectiveness of German Disease Management Programs (DMPs) in Patients with Type 2 Diabetes Mellitus and Coronary Heart Disease: Results from an Observational Longitudinal Study
  • Chapter 13
    The Impact of Coronary Artery Disease Risk Loci on Ischemic Heart Failure Severity and Prognosis: Association Analysis in the COntrolled ROsuvastatin MultiNAtional Trial in Heart Failure(CORONA)
  • Chapter 14
    The Trp719Arg Polymorphism of the KIF6 Gene and Coronary Heart Disease Risk: Systematic Review and Meta-Analysis
  • Chapter 15
    Update on the Collaborative Interventions for Circulation and Depression (COINCIDE) Trial: Changes to Planned Methodology of a Cluster Randomized Controlled Trial of Collaborative Care for Depression in People with Diabetes and/or Coronary Heart Disease
Readership: Students, academics, teachers and other people attending or interested in Coronary Heart Disease
Kayvan Bozorgmehr
Department of General Practice & Health Services Research, University Hospital Heidelberg, Heidelberg, Germany

Rosemary L. Simmonds
Service User Research Enterprise (SURE), Institute of Psychiatry, King’s College London, London, UK

Erika Turkstra
Centre for Applied Health Economics, School of Medicine, Griffith Health Institute, Griffith University, Brisbane, QLD, Australia

Christos Christodoulou
Second Department of Psychiatry, “Attikon” General Hospital, University of Athens Medical School, Athens 12462, Greece

Dietrich Rothenbacher
Institute of Epidemiology and Medical Biometry, Ulm University, Helmholtzstr 22, Ulm D-89081, Germany

Donna R Parker
Brown Center for Primary Care and Prevention, Memorial Hospital of Rhode Island, Pawtucket, USA

and more...
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top